Clinical Trials Directory

Trials / Unknown

UnknownNCT01133509

A Model for Implementation of Cervical Cancer Screening and HPV Vaccination the Emergency Department: a Pilot Study

A Model for the Implementation of the Cervical Cancer Screening and HPV Vaccination in the Emergency Department: a Pilot Study.

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Eastern Virginia Medical School · Academic / Other
Sex
Female
Age
18 Years – 26 Years
Healthy volunteers
Accepted

Summary

In this pilot study, we intend to demonstrate that a great portion of women at high risk (inadequate screening, HPV 16/18 and/or cytology) are presenting to the ED, cytology/ HPV testing via ThinPrep®Pap testTM and surveillance. We intend to provide improved access to healthcare and monitoring through administration of vaccine to eligible patients and 1 year follow up for patients involved in this study. Females meeting inclusion/exclusion criteria participating in the study (n=100) that have not had a cytology test in 2 or more years will be offered the Thin Prep® cytology test. This study will allow surveillance of disease through cytology and HPV DNA testing via collection of data using Thin Prep® cytology with reflex HPV DNA testing according to established guidelines as described below. Provide improved access to healthcare and monitoring through administration of vaccine for eligible females as established by guidelines. Patients will receive first vaccine in the ED and will have arranged follow up for administration of the 2 month and 6 month series of the HPV vaccination. Through data collection, we intend to determine if there is a need for vaccination and determine if patients are likely to follow up..

Conditions

Interventions

TypeNameDescription
DRUGGardasil0.5ml IM for three doses, Second and third dose to be given at 2 months and 6 months

Timeline

Start date
2009-09-01
Primary completion
2012-09-01
Completion
2012-10-01
First posted
2010-05-31
Last updated
2012-08-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01133509. Inclusion in this directory is not an endorsement.